These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37121798)

  • 1. Prevalence of poliovirus neutralizing antibodies in Italian population: A systematic review and meta-analysis.
    Tafuri S; Cuscianna E; Bianchi FP
    Vaccine; 2023 Jun; 41(27):4057-4063. PubMed ID: 37121798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
    Bianchi FP; Larocca AMV; Bozzi A; Spinelli G; Germinario CA; Tafuri S; Stefanizzi P
    Vaccine; 2021 May; 39(22):2989-2994. PubMed ID: 33933314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
    Opare JK; Akweongo P; Afari EA; Odoom JK
    Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of seroprevalence against poliovirus among Italian adolescents and adults.
    Lupi S; Stefanati A; Baldovin T; Roman A; Baldo V; Gabutti G
    Hum Vaccin Immunother; 2019; 15(3):677-682. PubMed ID: 30427738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010.
    Cardemil CV; Jonas A; Gerber S; Weldon WC; Oberste MS; Beukes A; Sawadogo S; Patel SV; Zeko S; Muroua C; Gaeb E; Wannemuehler K; Goodson JL
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S136-42. PubMed ID: 25316828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
    Hussain I; Mach O; Hamid NA; Bhatti ZS; Moore DD; Oberste MS; Khan S; Khan H; Weldon WC; Sutter RW; Bhutta ZA; Soofi SB
    Vaccine; 2018 Apr; 36(15):1921-1924. PubMed ID: 29510918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of poliovirus antibodies in Nigeria: refining strategies to sustain the eradication effort.
    Bolu O; Adamu U; Franka R; Umeokonkwo CD; An Q; Greby S; McDonald S; Mainou B; Mba N; Agala N; Archer WR; Braka F; Etapelong SG; Gashu TS; Siddique AR; Asekun A; Okoye M; Iriemenam N; Wiesen E; Swaminathan M; Ihekweazu C; Shuaib F
    Pan Afr Med J; 2023; 45(Suppl 2):2. PubMed ID: 38370104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
    Orenstein WA;
    Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination.
    Battistone A; Buttinelli G; Fiore S; Amato C; Bonomo P; Patti AM; Vulcano A; Barbi M; Binda S; Pellegrinelli L; Tanzi ML; Affanni P; Castiglia P; Germinario C; Mercurio P; Cicala A; Triassi M; Pennino F; Fiore L
    Appl Environ Microbiol; 2014 Aug; 80(15):4491-501. PubMed ID: 24814793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
    Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
    Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of immunity to poliovirus type 3: a lurking danger?
    Reinheimer C; Friedrichs I; Rabenau HF; Doerr HW
    BMC Infect Dis; 2012 Jan; 12():24. PubMed ID: 22280025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
    Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
    Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of polioviruses among university students in northern Italy.
    Baldo V; Baldovin T; Cocchio S; Lazzari R; Saracino E; Bertoncello C; Buja A; Trevisan A
    Clin Vaccine Immunol; 2012 Aug; 19(8):1292-5. PubMed ID: 22739695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
    Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
    BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy.
    Giammanco GM; Bechini A; Urone N; Bonura F; Li Muli S; De Grazia S; Bellini I; Tiscione E; Boccalini S; Nastasi A
    Hum Vaccin Immunother; 2018; 14(9):2248-2253. PubMed ID: 29771600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [POLIOMYELITIS ERADICATION--ONE STEP TO ACHIEVE THE GOAL].
    Ljubin-Sternak S; Kaić B; Vilibić-Čavlek T; Mlinarić-Galinović G
    Acta Med Croatica; 2014 Dec; 68(4-5):327-35. PubMed ID: 26285465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
    Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
    Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
    Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
    BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild and vaccine-derived poliovirus circulation, and implications for polio eradication.
    Lopalco PL
    Epidemiol Infect; 2017 Feb; 145(3):413-419. PubMed ID: 27866483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.